More European Countries Suspend AstraZeneca’s Vaccine Use

Sweden, Latvia, and Luxembourg have become the latest European countries to halt the use of AstraZeneca’s Coronavirus vaccine over safety concerns.

More than a dozen countries, mostly in Europe, have already suspended the use of AstraZeneca’s Coronavirus vaccine as a precautionary measure after a number of people suffered blood clots and brain hemorrhages after receiving the vaccine.


ALSO READ

Pakistani Player Wins Gold At Tent Pegging World Cup Qualifiers in India


Ireland, Bulgaria, Iceland, Denmark, Norway, Netherlands, Germany, Italy, Romania, France, Portugal, Slovenia, Spain, and Indonesia have halted the use of AstraZeneca’s COVID-19 vaccine over safety fears.

Thailand was the first non-European country to stop the use of AstraZeneca’s vaccine on 12 March, the day it was due to kick off the mass vaccination campaign. However, the suspension was brief as PM Prayuth Chanocha became the first person in the country to receive AstraZeneca’s vaccine on 16 March.

DR Congo has also postponed its mass vaccination campaign in light of the moves of the European countries. Congo had received 1.7 million doses of AstraZeneca’s under the COVAX scheme earlier this month.

Venezuela has decided against authorizing the use of the AstraZeneca vaccine as the country has been using Russia’s Sputnik V and China’s Sinopharm for its mass vaccination campaign.

On the other hand, the World Health Organization (WHO) and the European Medicines Agency (EMA), in light of AstraZeneca’s statement, have appealed to countries not to halt the vaccination campaigns.


ALSO READ

Pakistan Has The 2nd Worst Air Quality in The World: Report


In an official statement, AstraZeneca has stated that a review of its safety data, which is based on the experiences of 17 million individuals vaccinated across the UK and EU, revealed no evidence of an increased risk of blood clots.

Meanwhile, Pakistan is also set to import 45 million doses of AstraZeneca’s Coronavirus vaccine through COVAX. 15 million doses will reach Pakistan during H1 2021 while the remaining 30 million doses will be procured during H2 2021.

Note that AstraZeneca, the UK-based pharmaceutical company, had developed its COVID-19 vaccine in collaboration with Oxford University.

AstraZeneca had outsourced the large-scale manufacturing of its COVID-19 vaccine to Serum Institute of India, the world’s largest vaccine manufacturer, which claimed that it was producing more than 50 million doses per month to meet the global demand for AstraZeneca’s COVID-19 vaccine.



Get Alerts

Follow ProPakistani to get latest news and updates.


ProPakistani Community

Join the groups below to get latest news and updates.



>